The UK is likely to approve Covid-19 vaccines by Pfizer and BioNTech this week, sooner than the United States, reports The Telegraph.
Citing sources from the government, the media reported that UK regulators will begin making formal assessments of vaccines made by the company.
Meanwhile, the UK National Health Service (NHS) has been told to be ready to start vaccinating as early as 1 December. Every adult in the country will be vaccinated in April according to a draft plan by the NHS.
The distribution of vaccines for people between the ages of 18 and 50 is likely to begin in late January, where after high-risk groups, the elderly and frontline workers will be vaccinated.
However, health officials say it is still too early to make a vaccination schedule as it still depends on the approval and arrival of the vaccine in the country.
It was previously reported that the United States is expected to receive the first Covid-19 vaccine a day after the U.S. Food and Drug Administration (FDA) approved its use in mid-December.
The FDA announced on Friday that it would meet on December 10 to discuss whether the vaccine would be approved or not.
